Zeria Pharmaceutical Co., Ltd.Zeria Pharmaceutical Co., Ltd.Zeria Pharmaceutical Co., Ltd.

Zeria Pharmaceutical Co., Ltd.

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪88.86 B‬JPY
‪9.94 B‬JPY
‪87.31 B‬JPY
‪17.02 M‬
Beta (1Y)
0.44
Employees (FY)
‪1.75 K‬
Change (1Y)
−31 −1.74%
Revenue / Employee (1Y)
‪50.01 M‬JPY
Net income / Employee (1Y)
‪5.69 M‬JPY

About Zeria Pharmaceutical Co., Ltd.


CEO
Sachiaki Ibe
Headquarters
Tokyo
Founded
1955
ISIN
JP3428850006
FIGI
BBG000C1WXD1
Zeria Pharmaceutical Co., Ltd. engages in the manufacture, sale, import and export of pharmaceutical products. It operates through the following segments: Medical Pharmaceuticals and Consumer Healthcare. The Medical Pharmaceuticals segment deals with the research, development, and distribution of medical drugs. The Consumer Healthcare segment manufactures, supplies, and markets self-medication over-the-counter (OTC) drugs, health foods, quasi drugs, and cosmetics. The company was founded in December 22, 1955 and is headquartered in Tokyo, Japan.

Check out other big names from the same industry as 4559.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
1306
Next Funds TOPIX Exchange Traded Fund
Weight
0.01%
Market value
‪12.13 M‬
USD
1305
iFreeETF TOPIX
Weight
0.01%
Market value
‪5.76 M‬
USD
1308
Nikko Exchange Traded Index Fund TOPIX
Weight
0.01%
Market value
‪5.74 M‬
USD
1348
MAXIS TOPIX ETF
Weight
0.01%
Market value
‪1.72 M‬
USD
DXJ
WisdomTree Japan Hedged Equity Fund
Weight
0.03%
Market value
‪1.16 M‬
USD
1475
iShares Core TOPIX ETF
Weight
0.01%
Market value
‪945.56 K‬
USD
IJPA
iShares Core MSCI Japan IMI UCITS ETF
Weight
0.01%
Market value
‪471.66 K‬
USD
SJPE
iShares Core MSCI Japan IMI UCITS ETF EUR Hedged Accum
Weight
0.01%
Market value
‪471.66 K‬
USD
SJPD
iShares Core MSCI Japan IMI UCITS ETF
Weight
0.01%
Market value
‪471.66 K‬
USD
GWX
SPDR S&P International Small Cap ETF
Weight
0.04%
Market value
‪331.62 K‬
USD
1473
One ETF TOPIX
Weight
0.01%
Market value
‪300.68 K‬
USD

Explore more ETFs 

Frequently Asked Questions


The current price of 4559 is 1,999 JPY — it has decreased by −0.05% in the past 24 hours. Watch Zeria Pharmaceutical Co., Ltd. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TSE exchange Zeria Pharmaceutical Co., Ltd. stocks are traded under the ticker 4559.
4559 stock has risen by 0.40% compared to the previous week, the month change is a −5.58% fall, over the last year Zeria Pharmaceutical Co., Ltd. has showed a −14.94% decrease.
4559 reached its all-time high on Jan 21, 2014 with the price of 3,170 JPY, and its all-time low was 705 JPY and was reached on Mar 15, 2011. View more price dynamics on 4559 chart.
See other stocks reaching their highest and lowest prices.
4559 stock is 1.16% volatile and has beta coefficient of 0.44. Track Zeria Pharmaceutical Co., Ltd. stock price on the chart and check out the list of the most volatile stocks — is Zeria Pharmaceutical Co., Ltd. there?
Today Zeria Pharmaceutical Co., Ltd. has the market capitalization of ‪86.81 B‬, it has decreased by −0.39% over the last week.
Yes, you can track Zeria Pharmaceutical Co., Ltd. financials in yearly and quarterly reports right on TradingView.
Zeria Pharmaceutical Co., Ltd. is going to release the next earnings report on Nov 5, 2025. Keep track of upcoming events with our Earnings Calendar.
Zeria Pharmaceutical Co., Ltd. revenue for the last quarter amounts to ‪19.49 B‬ JPY, despite the estimated figure of ‪22.75 B‬ JPY. In the next quarter, revenue is expected to reach ‪22.15 B‬ JPY.
4559 net income for the last quarter is ‪1.09 B‬ JPY, while the quarter before that showed ‪1.71 B‬ JPY of net income which accounts for −36.20% change. Track more Zeria Pharmaceutical Co., Ltd. financial stats to get the full picture.
Zeria Pharmaceutical Co., Ltd. dividend yield was 2.08% in 2024, and payout ratio reached 20.85%. The year before the numbers were 2.06% and 25.09% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Oct 10, 2025, the company has ‪1.75 K‬ employees. See our rating of the largest employees — is Zeria Pharmaceutical Co., Ltd. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Zeria Pharmaceutical Co., Ltd. EBITDA is ‪17.21 B‬ JPY, and current EBITDA margin is 22.62%. See more stats in Zeria Pharmaceutical Co., Ltd. financial statements.
Like other stocks, 4559 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Zeria Pharmaceutical Co., Ltd. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Zeria Pharmaceutical Co., Ltd. technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Zeria Pharmaceutical Co., Ltd. stock shows the sell signal. See more of Zeria Pharmaceutical Co., Ltd. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.